(Q82742558)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132451%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132451%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

main subject

hepatocellular carcinoma

1 reference

1 reference

1 reference

Kazuhiro Kasai

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132451%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Akira Ushio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132451%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Yukiho Kasai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132451%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Kei Sawara

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132451%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Yasuhiro Miyamoto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132451%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Kanta Oikawa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132451%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Hidekatsu Kuroda

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132451%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Yasuhiro Takikawa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132451%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Kazuyuki Suzuki

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132451%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

4 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132451%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Clinical Oncology

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132451%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132451%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132451%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

221-229

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132451%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10147-010-0151-9

17 January 2020

exact match

0 references

cites work

Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review

1 reference

12 December 2020

A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE).

1 reference

12 December 2020

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches

1 reference

12 December 2020

Percutaneous ethanol injection therapy for the treatment of hepatocellular carcinoma

1 reference

12 December 2020

Evaluation of newly developed combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon alpha-2b for advanced hepatocellular carcinoma with portal venous invasion: preliminary results

1 reference

12 December 2020

Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model.

1 reference

12 December 2020

Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma

1 reference

12 December 2020

Sorafenib in advanced hepatocellular carcinoma

1 reference

12 December 2020

Changing incidence of hepatocellular carcinoma in Japan

1 reference

12 December 2020

Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines

1 reference

12 December 2020

[Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization (TAE)--significance of repetitive therapies and responses to them within 6 months after the first intervention]

1 reference

12 December 2020

Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma

1 reference

12 December 2020

Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation

1 reference

12 December 2020

Transcatheter arterial embolization (TAE) in treatment for hepatoma--analysis of three-year survivors

1 reference

12 December 2020

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Development of portal vein invasion and its outcome in hepatocellular carcinoma treated by transcatheter arterial chemo-embolization

1 reference

12 December 2020

Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.

1 reference

12 December 2020

Interferon effects upon fluorouracil metabolism by HL-60 cells

1 reference

12 December 2020

Treatment of cancer of the liver. Twenty years' experience with infusion and resection in 414 patients

1 reference

12 December 2020

Trends in mortality from primary liver cancer in Europe

1 reference

12 December 2020

Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion

1 reference

12 December 2020

Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy

1 reference

12 December 2020

Rising incidence of hepatocellular carcinoma in the United States

1 reference

12 December 2020

Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma.

1 reference

12 December 2020

Cellular basis for the inefficacy of 5-FU in human colon carcinoma.

1 reference

12 December 2020

Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group

1 reference

12 December 2020

Intraarterial chemotherapy of liver metastases: implantation of a microcatheter-port system with use of modified fixed catheter tip technique

1 reference

12 December 2020

Stimulation of 5-fluorouracil metabolic activation by interferon-alpha in human colon carcinoma cells

1 reference

12 December 2020

Hepatocellular carcinoma with portal tumor thrombus: analysis of factors determining prognosis

1 reference

12 December 2020

10.1007/S10147-010-0151-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132451%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference